Identifying pregnancy risks complications due to maternal fetal HBV and HCV at the Bertoua Regional Hospital in the East Region of Cameroon
- Author(s): Tatiana Jiengoué a , Olivier Lieuga a and Augustine Nji Asakizi a
- Institution: School of Health and Biomedical Sciences, Kesmonds International University of America
PAPER DETAILS
- Paper ID:Paper ID: 26005009
- Volume :IQRJ V05I02
- Issue:02
- May 2026
- ISSN: 2790-4296(Online)
- ISBN: 978-9956-504-74-9(Print)
Tatiana Jiengoué, Olivier Lieuga and Augustine Nji Asakizi (2026). Identifying pregnancy risks complications due to maternal-fetal HBV and HCV at the Bertoua Regional Hospital in the East Region of Cameroon. IQ Research Journal, 5(2), IQRJ-V05I02-26005009.
ABSTRACT
Results from a seven-year nationwide inpatient sample study demonstrate that HBV and HCV viruses are each associated with pregnancy complications. Maternal HBV or HCV carrier status is a cause for concern regarding both the course of pregnancy and the short term perinatal outcomes. Previous data conflict regarding the association of chronic HBV and HCV with adverse pregnancy outcomes, according to investigator Bing Chen, who presented the findings at the American Association for the study of liver Diseases. The main aim of this study is to identify HBV/HCV pregnancy risks complications. This cross sectional study at Bertoua Regional Hospital of Cameroon (June 2025 January 2026) aimed at identifying pregnancy risks complications due to maternal fetal HBV and HC V at the Bertoua Regional Hospital in Cameroon of pregnant women attending the maternity unit. The majority of them (62%) were aged within (19 28). (86.20%) of the pregnant women who were tested positive had experienced low birth weight, (79.31%) have know n preterm birth, (68.76%) had been admitted to the Neonatal intensive care unit while (65.51%) had children with congenital abnormalities, pregnant women having HCV were likely to develop risks complications like preterm birth, low weight birth due to the fact that HCV is generally associated with a higher risk of adverse pregnancy complications compared to HBV particularly regarding neonatal outcomes. However, data identifying maternal fetal HBV and HCV pregnancy risks complications among pregnant women ac ross both community and healthcare settings remain limited, pregnant women are sometimes
unaware of their pregnancy risks in their conditions; hence the need of this research study which goes in straight line with the World Health Organization elimination goals on viral Hepatitis.